Equels Thomas K.

Equels Thomas K. is listed in filings as CEO & President at AIM ImmunoTech Inc.. This profile follows SEC Form 4 activity through Mar 16, 2026, including purchase activity. Recent filings connect the profile to AIM ImmunoTech Inc. (AIM). The current snapshot covers public activity from Aug 12, 2024 to Mar 16, 2026. Reported amounts are shown as $50.0K to $824. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.